Clinical Trial: Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema

U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07489131) titled 'Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema' on March 19.

Brief Summary: This is a Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of AVT29 Compared with Eylea HD in Participants with Diabetic Macular Edema.

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Diabetic Macular Edema

Intervention: DRUG: AVT29 (proposed aflibercept HD biosimilar)

Patients will receive IVT injections of AVT29

DRUG: Eylea HD (aflibercept HD)

Patients will receive IVT injections of Eylea HD

Recruitment St...